New trial
PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New trial
An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors
Why it was picked newest record on or before this date
New paper
Functional Delivery of Nanoimmunotherapies in Pancreatic Ductal Adenocarcinoma: A Barrier-Informed Pharmaceutics Framework.
Why it was picked newest record on or before this date
New trial
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
Why it was picked newest record on or before this date
New paper
Early Local Tumour Control and Feasibility of Intratumoral P-32 Microparticle Implantation in Patients with Locally Advanced Pancreatic Cancer: A Prospective Single-Center Observational Cohort Study.
Why it was picked newest record on or before this date
Also today
New paper
NeoBridge: Biophysics-informed neoantigen prioritization and clonal architecture profiling in pancreatic cancer.
New paper
Outcomes of neoadjuvant chemoradiation versus chemotherapy alone for resected distal pancreatic adenocarcinoma.
New paper
SERPINB5 promotes pancreatic adenocarcinoma progression through FBXO32-mediated regulation of epithelial-mesenchymal transition.
New paper
Ultrasensitive Trace Sample Proteomics for Pancreatic Ductal Adenocarcinoma Diagnosis Empowered by Dual-Affinity Spherical Ln-MOFs.
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.